The PCMPA has slammed Moderna over an unapproved WhatsApp message that offered children 1,500 pounds sterling ($2,000) to ...
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...
The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor ...
Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development budget by about 20% over ...
GSK's decision not to advance the vaccine into Phase III trials ends its ambition to bring the first HSV vaccine to market.
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.
Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...
Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 ...
Moderna shares were hit a little over a month ago when the company cut its 2024 net sales guidance to a range of $3 billion to $3.5 billion from a previous $4 billion.
With the approval of Moderna's updated COVID-19 vaccine, doctors are hoping the shots will be available soon and Albertans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback